Latest filing published 16 Nov 2021 for Maxcyte, INC., €197k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Amanda Louise Murphy: trading record in brief
Amanda Louise Murphy is a declared insider of Maxcyte, Inc. (finance chief), with filings sourced from SEC (Form 4). In total, 6 filings cover trades dated from 12 November 2021 to 16 November 2021.
Sales make up the whole of the open-market record (3 sales, €1.6M). Outside the open market, there are 3 option exercises.
The newest entry dates from 16 November 2021: an option exercise of €238k, in Maxcyte, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Amanda Louise Murphy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 51,103 shares@ US$4.42100.0% of flowCommon StockSEC:0001209191-21-064884:0
1 of 1 declaration
